✦ LIBER ✦

454 Potential chemopreventive agents and PSA expression in the LNCAP model of human prostate cancer progression

✍ Scribed by D. Peternac; I. Klima; M.G. Cecchini; U.E. Studer; G.N. Thalmann

Book ID: 118645664
Publisher: Elsevier Science
Year: 2004
Tongue: English
Weight: 209 KB
Volume: 3
Category: Article
ISSN: 1569-9056
DOI: 10.1016/s1569-9056(04)90451-4

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

510 CHEMOPREVENTIVE AGENTS INTERFERE WIT

510 CHEMOPREVENTIVE AGENTS INTERFERE WITH PSA EXPRESSION IN THE LNCAP PROGRESSION MODEL

✍ G.N. Thalmann; D. Peternac; C.A. Rentsch; M.G. Cecchini; U.E. Studer 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 319 KB

Gene expression in the LNCaP human prost

Gene expression in the LNCaP human prostate cancer progression model: Progression associated expression in vitro corresponds to expression changes associated with prostate cancer progression in vivo

✍ Qian Chen; Jeffery T. Watson; Susan Ruth Marengo; Keith S. Decker; Ilsa Coleman; 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 500 KB

Gene expression profiles in the LNCAP mo

Gene expression profiles in the LNCAP model of human prostate cancer progression: Upregulation of osteomimetic peptides

✍ G. Thalmann; R. Sikes; M. Bisoffi; P. Nelson; A. Wetterwald; U. Studer; M. Cecch 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 180 KB

Inhibitory effect of matrine on the expr

Inhibitory effect of matrine on the expression of PSA and AR in prostate cancer cell line LNCaP

✍ Ke Chen; Zhiquan Hu; Tao Wang; Hui Guo; Zhangqun Ye 📂 Article 📅 2008 🏛 Springer-Verlag 🌐 Chinese ⚖ 403 KB

Expression of the transient receptor pot

Expression of the transient receptor potential vanilloid 1 (TRPV1) in LNCaP and PC-3 prostate cancer cells and in human prostate tissue

✍ María G. Sánchez; Ana M. Sánchez; Beatriz Collado; Sophie Malagarie-Cazenave; Nu 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 200 KB

Antitumor activity of mifepristone in th

Antitumor activity of mifepristone in the human LNCaP, LNCaP-C4, and LNCaP-C4-2 prostate cancer models in nude mice

✍ El Etreby, M. Fathy; Liang, Yayun; Johnson, Maribeth H.; Lewis, Ronald W. 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 144 KB 👁 2 views

## BACKGROUND. Antiprogestins are a promising new class of mammary tumor inhibitors with a unique mechanism of action. Previously published results also suggest a tumorinhibitory effect of antiprogestins in prostate cancer models. The objective of the present studies was to determine whether androg